v3.25.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Feb. 28, 2025
Net loss             $ 12,537,472 $ (4,464,079)  
Net cash outflows from operations             2,054,680 653,107  
Accumulated deficit             24,373,902 11,287,754  
Cash              
Aspire Biopharma Inc [Member]                  
Net loss             1,309,872 359,070  
Net cash outflows from operations             265,186 (11,136)  
Accumulated deficit             2,777,233 1,467,361  
Cash             3,633 $ 11,174  
Parent Company [Member]                  
Net loss $ 1,981,293 $ 15,941,328 $ 96,923 $ 230,970 $ 17,922,621 $ 327,893      
Net cash outflows from operations         2,891,838 $ 249,215      
Accumulated deficit 20,699,854       20,699,854   2,777,233    
Working capital deficit 9,567,500       9,567,500        
Cash $ 206,233       $ 206,233   $ 3,633    
Business combination proceeds                 $ 265,827
Business combination additional amount                 $ 3,000,000